1. Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study. (28th September 2015) Authors: Layton, A.M.; Schaller, M.; Homey, B.; Hofmann, M.A.; Bewley, A.P.; Lehmann, P.; Nohlgård, C.; Sarwer, D.B.; Kerrouche, N.; Ma, Y.M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 12(2015:Dec.) Page Start: 2405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany. (13th April 2020) Authors: Abraham, S.; Haufe, E.; Harder, I.; Heratizadeh, A.; Kleinheinz, A.; Wollenberg, A.; Weisshaar, E.; Augustin, M.; Wiemers, F.; Zink, A.; Biedermann, T.; von Kiedrowski, R.; Hilgers, M.; Worm, M.; Pawlak, M.; Sticherling, M.; Fell, I.; Handrick, C.; Schäkel, K.; Staubach, P. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Omalizumab prevents anaphylactoid reactions to mRNA COVID‐19 vaccine. (10th August 2021) Authors: Smola, A.; Samadzadeh, S.; Müller, L.; Adams, O.; Homey, B.; Albrecht, P.; Meller, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 11(2021) Page Start: e743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study. (15th July 2022) Authors: Dikmen, H.O.; Yilmaz, K.; Benoit, S.; Bernard, P.; Drenovska, K.; Gerdes, S.; Gläser, R.; Günther, C.; Homey, B.; Horváth, O.N.; Huilaja, L.; Joly, P.; Kiritsi, D.; Meller, S.; Patsatsi, A.; Sárdy, M.; Schauer, F.; Shahid, M.; Sticherling, M.; Tasanen, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: 2181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Human Papillomavirus‐type distribution in anogenital lesions of prepubertal children. (5th February 2021) Authors: Braun, S.A.; Silling, S.; Schloer, S.M.; Hofmann, S.C.; Fritzen, B.; Oellig, F.; Lehmann, P.; Homey, B.; Assaf, C.; Emmert, S.; Fölster‐Holst, R.; Tigges, C.; Wieland, U.; Kreuter, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 5(2021) Page Start: 1219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany. (13th February 2020) Authors: Heratizadeh, A.; Haufe, E.; Stölzl, D.; Abraham, S.; Heinrich, L.; Kleinheinz, A.; Wollenberg, A.; Weisshaar, E.; Augustin, M.; Wiemers, F.; Zink, A.; von Kiedrowski, R.; Hilgers, M.; Worm, M.; Pawlak, M.; Sticherling, M.; Fell, I.; Handrick, C.; Schäkel, K.; Staubach‐Renz, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 6(2020) Page Start: 1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany. (1st August 2020) Authors: Abraham, S.; Haufe, E.; Harder, I.; Heratizadeh, A.; Kleinheinz, A.; Wollenberg, A.; Weisshaar, E.; Augustin, M.; Wiemers, F.; Zink, A.; Biedermann, T.; von Kiedrowski, R.; Hilgers, M.; Worm, M.; Pawlak, M.; Sticherling, M.; Fell, I.; Handrick, C.; Schäkel, K.; Staubach, P. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dose‐response relationship of a new Timothy grass pollen allergoid in comparison with a 6‐grass pollen allergoid. Issue 11 (16th October 2017) Authors: Pfaar, O.; Hohlfeld, J. M.; Al‐Kadah, B.; Hauswald, B.; Homey, B.; Hunzelmann, N.; Schliemann, S.; Velling, P.; Worm, M.; Klimek, L. Journal: Clinical & experimental allergy Issue: Volume 47:Issue 11(2017) Page Start: 1445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation. Issue 11 (November 2014) Authors: Minai‐Fleminger, Y.; Gangwar, R. S.; Migalovich‐Sheikhet, H.; Seaf, M.; Leibovici, V.; Hollander, N.; Feld, M.; Moses, A. E.; Homey, B.; Levi‐Schaffer, F. Journal: Clinical & experimental allergy Issue: Volume 44:Issue 11(2014:Nov.) Page Start: 1335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Allergic sensitization to pegylated interferon‐α results in drug eruptions. Issue 7 (6th May 2015) Authors: Meller, S.; Gerber, P. A.; Kislat, A.; Hevezi, P.; Göbel, T.; Wiesner, U.; Kellermann, S.; Bünemann, E.; Zlotnik, A.; Häussinger, D.; Erhardt, A.; Homey, B. Journal: Allergy Issue: Volume 70:Issue 7(2015:Jul.) Page Start: 775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗